RE:RE:RE:RE:Observations from an outsiderI agree the inventory build is intriguing. Add in the prepayments and the potential is higher.
I take a slightly less agressive view on Q2 sales but think we are on track to be cashflow positive in Q3 (Jan-Mar) 2016. That would be an incredible outcome for a business that only started selling a few months ago.
Also, more news on OTC products imminent I think.
Looks good at this point IMO. Will be buying more on any weakness. Management are derisking this business progressively and methodically.
SDM